GGrantIndex
Sort

39,280 grants matching leukemia

MECHANISM OF INV(16) MEDIATED LEUKEMOGENESIS

$450,237
Vanderbilt University · R01 · FY2004 · CA

Doxorubicin Cardiomyopathy: Molecular Genetics & Rescue

$450,225
Laurence H Kedes · University Of Southern California · R01 · FY2008 · HL

COVID-19 research efforts

$450,222
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Mitochondrial regulation of hematopoietic stem cells

$450,213
Hans-Willem E Snoeck · Columbia University Health Sciences · R01 · FY2017 · HL

Mitochondrial regulation of hematopoietic stem cells

$450,213
Hans-Willem E Snoeck · Columbia University Health Sciences · R01 · FY2019 · HL

Mitochondrial regulation of hematopoietic stem cells

$450,213
Hans-Willem E Snoeck · Columbia University Health Sciences · R01 · FY2020 · HL

Transcription regulation in hematopoiesis

$450,207
Li Chai · Boston Children'S Hospital · P01 · FY2017 · HL

Transcription regulation in hematopoiesis

$450,207
Li Chai · Boston Children'S Hospital · P01 · FY2020 · HL

Transcription regulation in hematopoiesis

$450,207
Li Chai · Boston Children'S Hospital · P01 · FY2019 · HL

Interplay Between Cancer and Immune Cells on Targeted Therapy

$450,198
Peter Poon-Hang Lee · Stanford University · R01 · FY2011 · CA

Mutations and target genes in Adenoid Cystic Carcinoma

$450,117
Scott A. Ness · University Of New Mexico Health Scis Ctr · R01 · FY2012 · DE

Chemical disruption of Wnt-mediated signal transduction

$450,087
Lawrence Lum · Ut Southwestern Medical Center · R01 · FY2014 · CA

A mouse model of myelodysplastic syndrome progression and leukemic stem cells

$450,000
Yupo Ma · Nevada Cancer Institute · R01 · FY2009 · HL

Cancer and Leukemia Group B

$450,000
Richard L Schilsky · University Of Chicago · U10 · FY2007 · CA

A mouse model of myelodysplastic syndrome progression and leukemic stem cells

$450,000
Yupo Ma · Nevada Cancer Institute · R01 · FY2008 · HL

EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE

$450,000
Robert L Comis · Frontier Sci & Technology Rsch Fdn, Inc · U10 · FY2007 · CA

VISIBLE ANIMAL MODELS OF NEOPLASTIC DISEASE

$449,995
Stanford University · R33 · FY2001 · CA

GENETIC CHARACTERIZATION OF LEUKEMIA STEM CELLS IN CHEMICAL AND RADIATION INDUCED ACUTE MYELOGENOUS LEUKEMIA

$449,979
The Leland Stanford Junior University · · FY2010 · Department of the Army

B-CLL Biology: Impact of Combination Therapy

$449,968
Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · CA

CYP33 in MLL TARGET GENE REGULATION AND LEUKEMOGENESIS

$449,900
Manuel O Diaz · Loyola University Chicago · P01 · FY2009 · CA

Molecular Pathogenesis of AF10-Rearranged Leukemias

$449,812
Aniruddha J. Deshpande · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA

The Genetics of Susceptibility to Mouse Plasma Cell Tumors

$449,811
Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Children's Oncology Group NCORP Research Base

$449,700
Brad H. Pollock · Children'S Hosp Of Philadelphia · UG1 · FY2020 · CA

Assembly of Retroviruses and Interactions with Host Cellular Proteins

$449,665
Fadila Bouamr · Niaid Extramural Activities · Z01 · FY2007 · AI

Targeting the Notch:Myc axis in leukemia/lymphoma

$449,524
Warren S Pear · University Of Pennsylvania · R01 · FY2022 · CA